The problem of targeted delivery of antisense and siRNA oligonucleotides can be resolved into two distinct aspects. The first concerns devising ligand-oligonucleotide or ligand-carrier moieties that bind with high selectivity to receptors on the cell type of interest and that are efficiently internalized by endocytosis. The second concerns releasing oligonucleotides from pharmacologically inert endomembrane compartments so that they can access RNA in the cytosol or nucleus. In this review we will address both of these aspects. Thus we present information on three important receptor families, the integrins, the receptor tyrosine kinases, and the G protein-coupled receptors in terms of their suitability for targeted delivery of oligonucleotid...
Gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor super-family, ...
We describe the synthesis and characterization of a 5′ conjugate between a 2′-O-Me phosphorothioate ...
Attaining the full therapeutic utility of antisense and siRNA oligonucleotides will require understa...
The problem of targeted delivery of antisense and siRNA oligonucleotides can be resolved into two di...
One of the major constraints on the therapeutic use of oligonucleotides is inefficient delivery to t...
Significant progress is being made concerning the development of oligonucleotides as therapeutic age...
Oligonucleotides manifest much promise as potential therapeutic agents. However, understanding of ho...
Gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor superfamily, h...
The oligonucleotide therapeutics field has seen remarkable progress over the last few years with the...
Integrins have become key targets for molecular imaging and for selective delivery of anti-cancer ag...
The potential use of antisense and siRNA oligonucleotides as therapeutic agents has elicited a great...
Bioconjugates have been used to deliver therapeutic oligonucleotides to their pharmacological target...
There is mounting interest in developing antisense and siRNA oligonucleotides into therapeutic entit...
Genes are the major regulators of biological processes in every living thing. Problems with gene reg...
Short DNA or RNA oligonucleotides have tremendous potential as therapeutic agents. Because of their ...
Gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor super-family, ...
We describe the synthesis and characterization of a 5′ conjugate between a 2′-O-Me phosphorothioate ...
Attaining the full therapeutic utility of antisense and siRNA oligonucleotides will require understa...
The problem of targeted delivery of antisense and siRNA oligonucleotides can be resolved into two di...
One of the major constraints on the therapeutic use of oligonucleotides is inefficient delivery to t...
Significant progress is being made concerning the development of oligonucleotides as therapeutic age...
Oligonucleotides manifest much promise as potential therapeutic agents. However, understanding of ho...
Gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor superfamily, h...
The oligonucleotide therapeutics field has seen remarkable progress over the last few years with the...
Integrins have become key targets for molecular imaging and for selective delivery of anti-cancer ag...
The potential use of antisense and siRNA oligonucleotides as therapeutic agents has elicited a great...
Bioconjugates have been used to deliver therapeutic oligonucleotides to their pharmacological target...
There is mounting interest in developing antisense and siRNA oligonucleotides into therapeutic entit...
Genes are the major regulators of biological processes in every living thing. Problems with gene reg...
Short DNA or RNA oligonucleotides have tremendous potential as therapeutic agents. Because of their ...
Gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor super-family, ...
We describe the synthesis and characterization of a 5′ conjugate between a 2′-O-Me phosphorothioate ...
Attaining the full therapeutic utility of antisense and siRNA oligonucleotides will require understa...